Health care stocks rose Monday afternoon, with the NYSE Health Care Index adding 2% and the Health Care Select Sector SPDR Fund (XLV) climbing 2.4%.
The iShares Biotechnology ETF (IBB) jumped 4.6%.
In corporate news, President Donald Trump signed an executive order that will seek to lower prescription drug prices by tying the amount the government pays for some medicines to lower prices abroad. Trump also said he will seek to "cut out" pharmacy benefit managers. Shares of Pfizer (PFE), Johnson & Johnson (JNJ), Merck (MRK), AbbVie (ABBV) and Eli Lilly (LLY) rose. UnitedHealth (UNH), CVS Health (CVS) and Cigna (CI), the owners of the three largest PBMs, fell 0.3%, 4.6% and 6.2%.
KindlyMD (KDLY) shares soared 340% after the company said Monday it has entered into a definitive merger agreement with Nakamoto Holdings to start a Bitcoin treasury strategy.
CytomX Therapeutics (CTMX) shares surged 90% after the company reported better-than-expected Q1 results and "positive" interim trial results.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.